Events | 2019.07.19
Launch of AbbVie's Upadacitinib Expected to Cause a Stir in the US Rheumatoid Arthritis Market, According to Spherix Global Insights
EXTON, Pa., July 19, 2019 /PRNewswire/ -- The latest report included in Spherix\'s RealTime Dynamix™ Rheumatoid Arthritis (US) independent service comprises the responses of 101 US rheumatologists and captures the impact of new product launches and market events on prescribing behavior and ...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]global-insights-300887745.html
